| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | TMP | Common Stock | Tax liability | $10,832 | -129 | -0.93% | $83.97 | 13,735 | 09 Nov 2021 | Direct | |
| transaction | TMP | Common Stock | Tax liability | $11,756 | -140 | -1% | $83.97 | 13,595 | 09 Nov 2021 | Direct | F1 |
| transaction | TMP | Common Stock | Tax liability | $12,847 | -153 | -1.1% | $83.97 | 13,442 | 09 Nov 2021 | Direct | F1 |
| transaction | TMP | Common Stock | Award | $114,199 | +1,360 | +10% | $83.97 | 14,802 | 09 Nov 2021 | Direct | F2 |
| transaction | TMP | Common Stock | Options Exercise | $15,380 | +200 | +1.4% | $76.90 | 15,002 | 09 Nov 2021 | Direct | |
| transaction | TMP | Common Stock | Tax liability | $16,038 | -191 | -1.3% | $83.97 | 14,811 | 09 Nov 2021 | Direct | F3 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | TMP | Stock Appreciation Rights (SAR) | Options Exercise | $0 | -200 | -100% | $0.000000* | 0 | 09 Nov 2021 | Common Stock | 200 | $76.90 | Direct | F4 |
| Id | Content |
|---|---|
| F1 | Deemed disposition of shares to the Issuer to pay for taxes upon vesting of restricted stock. |
| F2 | Restricted stock was granted pursuant to the Tompkins Financial Corporation 2019 Equity Incentive Plan. Restricted stock grants have a five-year vesting schedule with 0% vesting in year one and 25% vesting in years two through five. The grant will expire ten years from the date of the grant. |
| F3 | Shares withheld for option cost and taxes. |
| F4 | Stock Appreciation Rights (SARs) were granted pursuant to the Tompkins Financial Corporation 2009 Equity Plan. SARs have a five-year vesting schedule, with 0% vesting in year one and 25% vesting in years two through five. When exercised, the SARs will be settled in Common Stock of the Company. The grant will expire ten years from the date of the grant. |